MedPath

Safety and Efficacy of Aneurysms Treated With Endovascular Devices

Recruiting
Conditions
Brain Aneurysm
Stroke
Intracranial Hemorrhages
Registration Number
NCT07175519
Lead Sponsor
King's College London
Brief Summary

In this project the investigators study the safety and efficacy of the recent endovascular devices used in treatment of brain aneurysms.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
5000
Inclusion Criteria
  • All patients undergoing endovascular aneurysm treatment.
Exclusion Criteria
  • All endovascular patients NOT undergoing aneurysm treatment e.g. stents used for stroke treatment; devices and materials used for dAVF, AVM treatments.
  • Insufficient background data available e.g., to determine size of aneurysm and device.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluate predictive factors of aneurysm recurrence after endovascular device embolization (efficacy).Done at short-term (30 days) post procedural and long term (up to 5 years) post procedural

Change of aneurysm from Raymond Roy (RR) classification I into RR II or RR III and correlating this with factors such as smoking.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Kings College Hospital, London

🇬🇧

London, United Kingdom

Kings College Hospital, London
🇬🇧London, United Kingdom
Thomas Booth
Contact
02032994828
thomasbooth@nhs.net

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.